Vyome Holdings, Inc (HIND): Nasdaq/NYSE listing notice — ReShape Lifesciences receives Nasdaq delisting notice for stockholders' equity below $2.5M

Vyome Holdings, Inc

As of Sept 30, 2024, stockholders' equity was $1,487,000, below Nasdaq's $2.5M minimum.
Company has 45 days to submit a compliance plan; if accepted, Nasdaq may grant up to 180-day extension.
Intends to monitor performance and consider available options to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Vyome Holdings, Inc received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 25, 2024, ReShape Lifesciences Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications department (the “Nasdaq Staff”) of the Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders’ equity for continued listing. As of September 30, 2024, the Company’s stockholders’ equity was $1,487,000. Under the Nasdaq Listing Rules the Company has 45 calendar days to submit a plan to reg

View on SEC.gov

Browse all listing & compliance notices →

Vyome Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001104659-24-124568

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.